BioIntelliSense’s BioSticker Receives FDA’s 510 (k) Clearance for Month-Long Vitals Monitoring

 BioIntelliSense’s BioSticker Receives FDA’s 510 (k) Clearance for Month-Long Vitals Monitoring

BioIntelliSense’s BioSticker Receives FDA’s 510 (k) Clearance for Month-Long Vitals Monitoring

Shots:

  • BioIntelliSense launches its medical-grade Data-as-a-Service (DaaS) platform and has received 510(k) clearance for BioSticker on-body sensor for scalable remote care in the US
  • The company has developed BioSticker device in collaboration with UC Health and its CARE Innovation Center to monitor the patient’s health in their home, thus reducing hospitalizations, emergency department visits and shorten hospital stays leading towards a cost-effective health
  • The BioSticker can monitor all vital activities for up to a continuous thirty days, providing physicians with an impressive set of data that can keep clues to patients’ diseases and conditions. The device is single-use and is disposed of after a patient is done wearing it

Click here ­to­ read full press release/ article | Ref: BioIntelliSense | Image: Wearable Technology

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post